Neurogene
Price & Volume
Stats
See more52W Range | $15.93-$43.66 |
Market Cap | $744.3M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$82.2M |
Diluted EPS | -$4.55 |
News
See moreYahoo Finance • 22 days ago
Neurogene Reports Positive Long-Term Phase 1/2 Data For Rett Syndrome Gene Therapy
Yahoo Finance • 5 months ago
Block upgraded, Duolingo downgraded: Wall Street's top analyst calls
Yahoo Finance • 5 months ago
Neurogene Gets FDA Breakthrough Tag For NGN-401 In Rett Syndrome; Stock Up
Yahoo Finance • last year
Short Report: Bears bite into Krispy Kreme after another weak earnings report
About
CEO | Dr. Rachel L. McMinn Ph.D. |
CFO | Ms. Christine Mikail Cvijic J.D. |
Address | 535 W 24th Street, New York, NY, United States, 10011 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |